South America ECMO Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Modality (Venoarterial ECMO, Venovenous ECMO, and Arteriovenous ECMO), Application (Respiratory and Cardiology), and Age Group (Adults, Pediatrics, and Neonates)
The South America ECMO market is expected to grow from US$ 53.00 million in 2022 to US$ 60.58 million by 2028. It is estimated to record a CAGR of 2.3% from 2022 to 2028.
Growing Adoption of ECMO in Lung Transplantation Procedures Bolsters South America ECMO Market Growth
Lung transplantation is a life-saving treatment option for patients suffering from end-stage lung diseases, such as COPD, Idiopathic pulmonary fibrosis (IPF), and cystic fibrosis, to improve the quality of life. ECMO is a versatile tool used in all lung transplantation phases, such as preoperative, intraoperative, and postoperative periods. It acts as a bridge in patient undergoing lung transplantation. Therefore, the adoption of ECMO during lung transplantation is growing rapidly to manage patients with life-threatening lung disease. Primary graft dysfunction (PGD) is the leading cause of death after a lung transplant. Thus, ECMO is used penultimately in treating PGD post lung transplantation. Thus, the demand for ECMO equipment is growing for treating the patients suffering from PGD.
South America ECMO Market Overview
The South America ECMO market is segmented into Brazil, Argentina, and the Rest of South America. Brazil dominated the market in 2022. According to World Heart Federation, noncommunicable diseases such as cardiovascular disease accounts for 74% of total deaths in Brazil. According to Global Burden Study (GBD) and Brazilian Unified Health System, cardiovascular disease was the leading cause of death in Brazil in 2019. Due to the increasing aging population in Brazil, the prevalence of cardiovascular diseases is increasing each year. According to GBD, the number of ischemic heart disease (IHD) cases reached 4 million in 2019. Further, about 171,246 deaths were reported due to IHD, which accounted for 43% of cardiovascular deaths and 12% of total deaths in Brazil in 2019. Thus, growing cardiovascular disease cases in Brazil are driving the ECMO market growth in the country.
South America ECMO Market Revenue and Forecast to 2028 (US$ Million)
Get more information on this report :
South America ECMO Market Segmentation
The South America ECMO market is segmented based on modality, application, age group, and country.
Based on modality, the South America ECMO market is segmented into venoarterial ECMO, venovenous ECMO, and arteriovenous ECMO. The venoarterial ECMO segment held the largest market share in 2022.
Based on application, the South America ECMO market is bifurcated into respiratory and cardiology. The respiratory segment held a larger market share in 2022.
Based on age group, the South America ECMO market is segmented into adults, pediatrics, and neonates. The adults segment held the largest market share in 2022.
Based on country, the South America ECMO market has been categorized into Brazil, Argentina, and the Rest of South America. Our regional analysis states that Brazil dominated the market in 2022.
ABIOMED Inc, Braile Biomedica, Fresenius Medical Care AG & Co KGaA, Getinge AB, LivaNova Plc, Medtronic Plc, MicroPort Scientific Corporation, Nipro Medical Corporation, and Terumo Group are the leading companies operating in the South America ECMO market.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 South America ECMO Market – By Modality
1.3.2 South America ECMO Market – By Application
1.3.3 South America ECMO Market – By Age Group
1.3.4 South America ECMO Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South America ECMO Market – Market Landscape
4.1 Overview
4.2 South America PEST Analysis
4.3 Experts Opinion
5. South America ECMO Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Cardiovascular Diseases and Respiratory Failures
5.1.2 Growing Adoption of ECMO in Lung Transplantation Procedures
5.2 Market Restraints
5.2.1 Complications Associated with ECMO
5.3 Market Opportunities
5.3.1 Increasing Survival Rates with ECMO
5.4 Future Trends
5.4.1 Surging Product Developments and Approvals
5.5 Impact Analysis
6. ECMO Market – South America Analysis
6.1 South America ECMO Market Revenue Forecast & Analysis
7. South America ECMO Market Analysis – By Modality
7.1 Overview
7.2 South America ECMO Market Share by Modality 2021 & 2028 (%)
7.3 Venoarterial ECMO
7.3.1 Overview
7.3.2 Venoarterial ECMO: ECMO Market Revenue and Forecast to 2028 (US$ Million)
7.4 Venovenous ECMO
7.4.1 Overview
7.4.2 Venovenous ECMO: ECMO Market Revenue and Forecast to 2028 (US$ Million)
7.5 Arteriovenous ECMO
7.5.1 Overview
7.5.2 Arteriovenous ECMO: ECMO Market Revenue and Forecast to 2028 (US$ Million)
8. South America ECMO Market Analysis – By Application
8.1 Overview
8.2 South America ECMO Market, By Application 2021 & 2028 (%)
8.4 Respiratory
8.4.1 Overview
8.4.2 Respiratory Market Revenue and Forecast to 2028 (US$ Mn)
8.5 Cardiology
8.5.1 Overview
8.5.2 Cardiology Market Revenue and Forecast to 2028 (US$ Mn)
9. South America ECMO Market Analysis – By Age Group
9.1 Overview
9.2 South America ECMO Market, By Age Group 2021 & 2028 (%)
9.3 Adults
9.3.1 Overview
9.3.2 Adults Market Revenue and Forecast to 2028 (US$ Mn)
9.4 Pediatrics
9.4.1 Overview
9.4.2 Pediatrics Market Revenue and Forecast to 2028 (US$ Mn)
9.5 Neonates
9.5.1 Overview
9.5.2 Neonates Market Revenue and Forecast to 2028 (US$ Mn)
10. South America ECMO Market – Country Analysis
10.1 Overview
10.1.1 South America: ECMO, by Country, 2021 & 2028 (%)
10.1.1.1 Brazil: ECMO – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 Brazil: ECMO – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3 Brazil: ECMO, by Modality, 2019-2028 (US$ Million)
10.1.1.1.4 Brazil: ECMO, by Application, 2019-2028 (US$ Million)
10.1.1.1.5 Brazil: ECMO, by Age Group, 2019-2028 (US$ Million)
10.1.1.2 Argentina: ECMO – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Argentina: ECMO – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3 Argentina: ECMO, by Modality, 2019-2028 (US$ Million)
10.1.1.2.4 Argentina: ECMO, by Application, 2019-2028 (US$ Million)
10.1.1.2.5 Argentina: ECMO, by Age Group, 2019-2028 (US$ Million)
10.1.1.3 Rest of South America: ECMO – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 Rest of South America: ECMO – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3 Rest of South America: ECMO, by Modality, 2019-2028 (US$ Million)
10.1.1.3.4 Rest of South America: ECMO, by Application, 2019-2028 (US$ Million)
10.1.1.3.5 Rest of South America: ECMO, by Age Group, 2019-2028 (US$ Million)
11. Industry Landscape
11.1 Overview
11.2 Inorganic Growth Strategies
11.2.1 Overview
11.3 Organic Growth Strategies
11.3.1 Overview
12. Company Profiles
12.1 Terumo Group
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Medtronic Plc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 MicroPort Scientific Corporation
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 LivaNova Plc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Nipro Medical Corporation
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Getinge AB
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Braile Biomedica
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Fresenius Medical Care AG & Co KGaA
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 ABIOMED Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. South America ECMO Market – Revenue and Forecast to 2028 (US$ Million)
Table 2. Brazil ECMO Market, by Modality – Revenue and Forecast to 2028 (USD Million)
Table 3. Brazil ECMO Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 4. Brazil ECMO Market, by Age Group – Revenue and Forecast to 2028 (USD Million)
Table 5. Argentina ECMO Market, by Modality – Revenue and Forecast to 2028 (USD Million)
Table 6. Argentina ECMO Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 7. Argentina ECMO Market, by Age Group – Revenue and Forecast to 2028 (USD Million)
Table 8. Rest of South America ECMO Market, by Modality – Revenue and Forecast to 2028 (USD Million)
Table 9. Rest of South America ECMO Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 10. Rest of South America ECMO Market, by Age Group – Revenue and Forecast to 2028 (USD Million)
Table 11. Recent Inorganic Growth Strategies
Table 12. Recent Organic Growth Strategies
Table 13. Glossary of Terms
LIST OF FIGURES
Figure 1. South America ECMO Market Segmentation
Figure 2. South America ECMO Market, By Country
Figure 3. South America ECMO Market Overview
Figure 4. South America ECMO Market, By Modality
Figure 5. South America ECMO Market, By Country
Figure 7. South America: PEST Analysis
Figure 8. Experts Opinion
Figure 9. Impact Analysis: South America ECMO Market
Figure 10. South America ECMO Market – Revenue Forecast and Analysis
Figure 11. South America ECMO Market Share by Modality 2021 & 2028 (%)
Figure 12. Venoarterial ECMO: South America ECMO Market Revenue and Forecast To 2028 (US$ Million)
Figure 13. Venovenous ECMO: South America ECMO Market Revenue and Forecast To 2028 (US$ Million)
Figure 14. Arteriovenous ECMO: South America ECMO Market Revenue and Forecast To 2028 (US$ Million)
Figure 15. South America ECMO Market, by Application 2021 & 2028 (%)
Figure 16. Respiratory : South America ECMO Market Revenue and Forecasts To 2028 (US$ MN)
Figure 17. Cardiology : South America ECMO Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 18. South America ECMO Market, by Age Group 2021 & 2028 (%)
Figure 19. Adults : South America ECMO Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 20. Pediatrics : South America ECMO Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 21. Neonates : South America ECMO Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 22. South America: ECMO Market, by Key Country – Revenue (2021) (US$ Million)
Figure 23. South America: ECMO, by Country, 2021 & 2028 (%)
Figure 24. Brazil: ECMO – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Argentina: ECMO – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Rest of South America: ECMO – Revenue and Forecast to 2028 (US$ Million)
- ABIOMED Inc
- Braile Biomedica
- Fresenius Medical Care AG & Co KGaA
- Getinge AB
- LivaNova Plc
- Medtronic Plc
- MicroPort Scientific Corporation
- Nipro Medical Corporation
- Terumo Group
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South America ECMO market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the South America ECMO market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth South America market trends and outlook coupled with the factors driving the ECMO market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution